Title
Inhibition of Angiogenesis Associated with Ovarian Cancer By Nanoparticles of Cerium Oxide (CIP)
Abstract
The invention provides a method of treating ovarian cancer in a mammal, the method inhibits angiogenesis associated with the cancer and comprises the parenteral administration to the mammal of an effective amount of cerium oxide nanoparticles having a predominance of Ce+3.
Document Type
Patent
Patent Number
US 8,916,199
Application Serial Number
13/182,522
Issue Date
12-23-2014
Current Assignee
Joint Assignment w/UCFRF: Mayo Clinic Rochester d/b/a Mayo Clinic
Assignee at Issuance
Joint Assignment w/UCFRF: Mayo Clinic Rochester d/b/a Mayo Clinic
College
NanoScience Technology Center
Department
NanoScience Technology Center
Allowance Date
7-31-2014
Filing Date
7-14-2011
Assignee at Filing
Joint Assignment w/UCFRF: Mayo Clinic Rochester d/b/a Mayo Clinic
Filing Type
Nonprovisional Application Record
Donated
no
Recommended Citation
Seal, Sudipta; Giri, Shailendra; Karakoti, Ajay; and Shridhar, Viji, "Inhibition of Angiogenesis Associated with Ovarian Cancer By Nanoparticles of Cerium Oxide (CIP)" (2014). UCF Patents. 268.
https://stars.library.ucf.edu/patents/268